VABOMERE Shows Higher Cure Rate in Patients with CRE Infections Vs. Best Available Therapy

preview_player
Показать описание
Michael N. Dudley, PharmD, senior vice president and head of R&D at the Medicines Company, explains how VABOMERE was associated with a higher overall cure rate and lower mortality compared with
  1. Contagion_Live
  2. VABOMERE
  3. CRE
  4. Michael Dudley
  5. ID Week
  6. bete-lactam
Рекомендации по теме
VABOMERE Shows Higher 0:02:12

VABOMERE Shows Higher Cure Rate in Patients with CRE Infections Vs. Best Available Therapy

FINPHARM Closing Conference 1:40:48

FINPHARM Closing Conference - Antibiotic Crises: A Global Ward Round - Panel 3

New Antibiotics for 0:58:09

New Antibiotics for the Treatment of Drug Resistant Gram Negative Infections

Gram-Negative NIs: Vabomere 0:03:12

Gram-Negative NIs: Vabomere and the TANGO II Study

Using Ceftolozane/Tazobactam to 0:02:38

Using Ceftolozane/Tazobactam to Treat Pseudomonas Aureginosa

Contagion Top 5 0:00:43

Contagion Top 5 for the Week of August 20th

FDA approves Zerbaxa 0:00:23

FDA approves Zerbaxa

Renee Ackley, PharmD, 0:02:48

Renee Ackley, PharmD, BCPS: Comparing Agents for Treating CRE

Superbug infection resistant 0:00:37

Superbug infection resistant to all FDA-approved antibiotics

Mechanisms of Gram 0:55:19

Mechanisms of Gram Negative Resistance -- Austin Morrison, PharmD

Antibiotic Resistant ‘Nightmare 0:00:38

Antibiotic Resistant ‘Nightmare Bacteria’ Spreading In U.S., CDC Warns

#Omadacycline | Uses, 0:04:49

#Omadacycline | Uses, Dosage, Side Effects & Mechanism | Nuzyra

The NOW 'FDA 0:00:58

The NOW 'FDA antibiotic warning'

New Antimicrobials and 0:45:25

New Antimicrobials and their Spectrum of Coverage Webinar

Exploring Cephalosporin/β-Lactamase Inhibitor 0:05:28

Exploring Cephalosporin/β-Lactamase Inhibitor Combinations for Treatment of Pseudomonas

CRE Bacteria Infection 0:02:30

CRE Bacteria Infection : Causes, Diagnosis, Symptoms, Treatment, Prognosis

Gram-Negative NIs: Cephalosporin/β-Lactamase 0:06:12

Gram-Negative NIs: Cephalosporin/β-Lactamase Inhibitors

Prognosis of Babies 0:01:54

Prognosis of Babies with Zika-related Complications

Mayo Clinic gastroenterologist 0:01:02

Mayo Clinic gastroenterologist on CRE bacteria

Evaluating CAZ-AVI Against 0:01:53

Evaluating CAZ-AVI Against Antibiotic-Resistant Gram-Negative Organisms

FDA Aproves Avycaz 0:00:33

FDA Aproves Avycaz

New or Upcoming 0:05:52

New or Upcoming Treatment Options for MDR Bacteria

Surgery Grandrounds 0:00:19

Surgery Grandrounds

CRE Infection: Causes, 0:06:31

CRE Infection: Causes, Symptoms & Treatment